0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 21-40 of 905 Articles
JAMA Oncology | 
Original Investigation |  Open Access
Sant P. Chawla, MD; Zsuzsanna Papai, MD; Guzel Mukhametshina, MD; et al.
JAMA Oncol. 2015;1(9):1272-1280. doi:10.1001/jamaoncol.2015.3101.
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Rebecca M. Prince, MBBS, FRACP; Eshetu G. Atenafu, MSc, PStat; Monika K. Krzyzanowska, MD, MPH, FRCPC
JAMA Oncol. 2015;1(9):1333-1339. doi:10.1001/jamaoncol.2015.3440.
Includes: Supplemental Content

JAMA Ophthalmology | 
Brief Report | 
Jasmine H. Francis, MD; Brian P. Marr, MD; Scott E. Brodie, MD, PhD; et al.
JAMA Ophthalmol. 2015;133(12):1459-1463. doi:10.1001/jamaophthalmol.2015.3119.

JAMA Oncology | 
Original Investigation | 
Takeo Fujii, MD, MPH; Fanny Le Du, MD; Lianchun Xiao, MS; et al.
JAMA Oncol. 2015;1(9):1311-1318. doi:10.1001/jamaoncol.2015.3062.
Includes: Supplemental Content

JAMA Ophthalmology | 
JAMA Ophthalmology Clinical Challenge | 
Enchun M. Liu, MD; Rithwick Rajagopal, MD, PhD; M. Gilbert Grand, MD
JAMA Ophthalmol. 2015;133(12):1469-1470. doi:10.1001/jamaophthalmol.2015.1957.

JAMA Oncology | 
Invited Commentary | 
Elisabete Weiderpass, MD, MSc, PhD; Harri Vainio, MD, PhD
JAMA Oncol. 2015;1(9):1291-1292. doi:10.1001/jamaoncol.2015.3270.

JAMA Oncology | 
Original Investigation | 
Marcus G. K. Cumberbatch, MBBS, BSc, MSc; Angela Cox, PhD; Dawn Teare, PhD; et al.
JAMA Oncol. 2015;1(9):1282-1290. doi:10.1001/jamaoncol.2015.3209.
Includes: CME, Supplemental Content

JAMA Oncology | 
Editor's Note |  FREE ONLINE FIRST
Charles R. Thomas Jr, MD, PhD
JAMA Oncol. Published online November 25, 2015. doi:10.1001/jamaoncol.2015.4087

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
David Cella, PhD
JAMA Oncol. Published online November 25, 2015. doi:10.1001/jamaoncol.2015.4683

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Benjamin Movsas, MD; Chen Hu, PhD; Jeffrey Sloan, PhD, HSR; et al.
JAMA Oncol. Published online November 25, 2015. doi:10.1001/jamaoncol.2015.3969
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Nikhil C. Munshi, MD
JAMA Oncol. 2015;1(8):1035-1036. doi:10.1001/jamaoncol.2015.3015.

JAMA Oncology | 
Original Investigation | 
Ola Landgren, MD, PhD; Youn K. Shim, PhD; Joel Michalek, PhD; et al.
JAMA Oncol. 2015;1(8):1061-1068. doi:10.1001/jamaoncol.2015.2938.

JAMA Psychiatry | 
Viewpoint | 
Ian R. H. Rockett, PhD, MPH; Eric D. Caine, MD
JAMA Psychiatry. 2015;72(11):1069-1070. doi:10.1001/jamapsychiatry.2015.1418.

JAMA Pediatrics | 
Original Investigation | 
Brian A. Primack, MD, PhD; Samir Soneji, PhD; Michael Stoolmiller, PhD; et al.
JAMA Pediatr. 2015;169(11):1018-1023. doi:10.1001/jamapediatrics.2015.1742.

JAMA Oncology | 
Brief Report | 
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD
JAMA Oncol. 2015;1(8):1133-1134. doi:10.1001/jamaoncol.2015.1713.

JAMA | 
The JAMA Forum |  FREE
Howard Koh, MD, MPH
JAMA. 2015;314(14):1437-1438. doi:10.1001/jama.2015.12346.

JAMA | 
Original Investigation | 
Beth Han, MD, PhD, MPH; Wilson M. Compton, MD, MPE; Christopher M. Jones, PharmD, MPH; et al.
JAMA. 2015;314(14):1468-1478. doi:10.1001/jama.2015.11859.
Includes: CME, Supplemental Content

JAMA Internal Medicine | 
Viewpoint | 
Robert C. McMillen, PhD; Mark A. Gottlieb, JD; Jonathan P. Winickoff, MD, MPH
JAMA Intern Med. 2015;175(10):1603-1604. doi:10.1001/jamainternmed.2015.4436.

JAMA Dermatology | 
Original Investigation | 
Giuliana Carlos, MBBS; Rachael Anforth, BMed; Arthur Clements, BSc (Med), MBBS; et al.
JAMA Dermatol. 2015;151(10):1103-1109. doi:10.1001/jamadermatol.2015.1745.

JAMA Oncology | 
Invited Commentary | 
Shyam K. Tanguturi, MD; Jennifer R. Bellon, MD
JAMA Oncol. 2015;1(7):941-942. doi:10.1001/jamaoncol.2015.2605.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Research Letter  | 
Major Causes of Injury Death and the Life Expectancy Gap Between the United States and Other High-Income Countries
Andrew Fenelon, PhD; Li-Hui Chen, PhD; Susan P. Baker, MPH
JAMA
News From the Centers for Disease Control and Prevention  | 
Opioid Overdoses Continue to Climb

JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.